296 related articles for article (PubMed ID: 25379018)
61. Telomere dysfunction promotes genome instability and metastatic potential in a K-ras p53 mouse model of lung cancer.
Perera SA; Maser RS; Xia H; McNamara K; Protopopov A; Chen L; Hezel AF; Kim CF; Bronson RT; Castrillon DH; Chin L; Bardeesy N; Depinho RA; Wong KK
Carcinogenesis; 2008 Apr; 29(4):747-53. PubMed ID: 18283039
[TBL] [Abstract][Full Text] [Related]
62. Mutations in the promoter of the telomerase gene
Chiba K; Lorbeer FK; Shain AH; McSwiggen DT; Schruf E; Oh A; Ryu J; Darzacq X; Bastian BC; Hockemeyer D
Science; 2017 Sep; 357(6358):1416-1420. PubMed ID: 28818973
[No Abstract] [Full Text] [Related]
63. The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.
Mzahma R; Kharrat M; Fetiriche F; Bouasker ; Ben Moussa M; Ben Safta Z; Dziri C; Zaouche A; Chaabouni-Bouhamed H
Tumour Biol; 2015 Nov; 36(11):8703-13. PubMed ID: 26047604
[TBL] [Abstract][Full Text] [Related]
64. Telomere dysfunction in Tert knockout mice delays Braf
Zhang J; Zhang F; Porter KI; Dakup PP; Wang S; Robertson GP; Gaddameedhi S; Zhu J
Int J Cancer; 2024 Feb; 154(3):548-560. PubMed ID: 37727982
[TBL] [Abstract][Full Text] [Related]
65. Analysis of telomeric repeats and telomerase activity in human colon carcinoma cells with gene amplification.
Bolzán AD; Páez GL; Bianchi MS; Bianchi NO
Cancer Genet Cytogenet; 2000 Jul; 120(2):166-70. PubMed ID: 10942811
[TBL] [Abstract][Full Text] [Related]
66. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia.
Leedham SJ; Graham TA; Oukrif D; McDonald SA; Rodriguez-Justo M; Harrison RF; Shepherd NA; Novelli MR; Jankowski JA; Wright NA
Gastroenterology; 2009 Feb; 136(2):542-50.e6. PubMed ID: 19103203
[TBL] [Abstract][Full Text] [Related]
67. Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence.
Valls Bautista C; Piñol Felis C; Reñé Espinet JM; Buenestado García J; Viñas Salas J
Rev Esp Enferm Dig; 2009 Mar; 101(3):179-86. PubMed ID: 19388798
[TBL] [Abstract][Full Text] [Related]
68. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer.
Attolini CS; Cheng YK; Beroukhim R; Getz G; Abdel-Wahab O; Levine RL; Mellinghoff IK; Michor F
Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17604-9. PubMed ID: 20864632
[TBL] [Abstract][Full Text] [Related]
69. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.
Lin TT; Letsolo BT; Jones RE; Rowson J; Pratt G; Hewamana S; Fegan C; Pepper C; Baird DM
Blood; 2010 Sep; 116(11):1899-907. PubMed ID: 20538793
[TBL] [Abstract][Full Text] [Related]
70. Premature aging in telomerase-deficient zebrafish.
Anchelin M; Alcaraz-Pérez F; Martínez CM; Bernabé-García M; Mulero V; Cayuela ML
Dis Model Mech; 2013 Sep; 6(5):1101-12. PubMed ID: 23744274
[TBL] [Abstract][Full Text] [Related]
71. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.
Olbertova H; Plevova K; Pavlova S; Malcikova J; Kotaskova J; Stranska K; Spunarova M; Trbusek M; Navrkalova V; Dvorackova B; Tom N; Pal K; Jarosova M; Brychtova Y; Panovska A; Doubek M; Pospisilova S
BMC Cancer; 2022 Feb; 22(1):137. PubMed ID: 35114947
[TBL] [Abstract][Full Text] [Related]
72. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.
Chin L; Artandi SE; Shen Q; Tam A; Lee SL; Gottlieb GJ; Greider CW; DePinho RA
Cell; 1999 May; 97(4):527-38. PubMed ID: 10338216
[TBL] [Abstract][Full Text] [Related]
73. Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response.
Lopez-Doriga A; Valle L; Alonso MH; Aussó S; Closa A; Sanjuan X; Barquero D; Rodríguez-Moranta F; Sanz-Pamplona R; Moreno V
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2992-3000. PubMed ID: 29908233
[TBL] [Abstract][Full Text] [Related]
74. The roles of telomerase in the generation of polyploidy during neoplastic cell growth.
Christodoulidou A; Raftopoulou C; Chiourea M; Papaioannou GK; Hoshiyama H; Wright WE; Shay JW; Gagos S
Neoplasia; 2013 Feb; 15(2):156-68. PubMed ID: 23441130
[TBL] [Abstract][Full Text] [Related]
75. Mutant p53 in colon cancer.
Nakayama M; Oshima M
J Mol Cell Biol; 2019 Apr; 11(4):267-276. PubMed ID: 30496442
[TBL] [Abstract][Full Text] [Related]
76. Differences in telomerase activity between colon and rectal cancer.
Ayiomamitis GD; Notas G; Zaravinos A; Zizi-Sermpetzoglou A; Georgiadou M; Sfakianaki O; Kouroumallis E
Can J Surg; 2014 Jun; 57(3):199-208. PubMed ID: 24869613
[TBL] [Abstract][Full Text] [Related]
77. Behaviour of telomere and telomerase during aging and regeneration in zebrafish.
Anchelin M; Murcia L; Alcaraz-Pérez F; García-Navarro EM; Cayuela ML
PLoS One; 2011 Feb; 6(2):e16955. PubMed ID: 21347393
[TBL] [Abstract][Full Text] [Related]
78. Telomerase expression in amyotrophic lateral sclerosis (ALS) patients.
De Felice B; Annunziata A; Fiorentino G; Manfellotto F; D'Alessandro R; Marino R; Borra M; Biffali E
J Hum Genet; 2014 Oct; 59(10):555-61. PubMed ID: 25142509
[TBL] [Abstract][Full Text] [Related]
79. Telomere fusions in early human breast carcinoma.
Tanaka H; Abe S; Huda N; Tu L; Beam MJ; Grimes B; Gilley D
Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14098-103. PubMed ID: 22891313
[TBL] [Abstract][Full Text] [Related]
80. Study of Telomere Dysfunction in TP53 Mutant LoVo Cell Lines as a Model for Genomic Instability.
Samassekou O; Bastien N; Yan J; Mai S; Drouin R
Methods Mol Biol; 2018; 1769():209-230. PubMed ID: 29564827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
